Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 68(22): 9147-56, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-19010886

ABSTRACT

Podosomes mediate cell migration and invasion by coordinating the reorganization of actin cytoskeleton and focal matrix degradation. MMP and serine proteases have been found to function at podosomes. The lysosomal cysteine cathepsins, a third major class of matrix-degrading enzymes involved in tumor invasion and tissue remodeling, have yet to be linked to podosomes with the exception of cathepsin K in osteoclasts. Using inhibitors and shRNA-mediated depletion, we show that cathepsin B participates in podosomes-mediated focal matrix degradation and invasion in v-Src-transformed fibroblasts. We observed that lysosomal marker LAMP-1 localized at the center of podosome rosettes protruding into extracellular matrix using confocal microscopy. Time-lapse live-cell imaging revealed that lysosomal vesicles moved to and fused with podosomes. Disruption of lysosomal pH gradient with Bafilomycin A1, chloroquine, or ammonium chloride greatly enhanced the formation of podosomes and increased the matrix degradation. Live-cell imaging showed that actin structures, induced shortly after Bafilomycin A1 treatment, were closely associated with lysosomes. Overall, our results suggest that cathepsin B, delivered by lysosomal vesicles, is involved in the matrix degradtion of podosomes.


Subject(s)
Actins/physiology , Cathepsin B/physiology , Cell Transformation, Neoplastic , Cellular Structures/physiology , Extracellular Matrix/metabolism , Genes, src , Lysosomes/physiology , Animals , Cathepsin B/antagonists & inhibitors , Fibroblasts , Gelatin/metabolism , Lysosomal Membrane Proteins/analysis , Lysosomal Membrane Proteins/physiology , Macrolides/pharmacology , Mice , NIH 3T3 Cells , Neoplasm Invasiveness
2.
J Biol Chem ; 282(22): 16577-84, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17426037

ABSTRACT

The ATM protein kinase is mutated in ataxia telangiectasia, a genetic disease characterized by defective DNA repair, neurodegeneration, and growth factor signaling defects. The activity of ATM kinase is activated by DNA damage, and this activation is required for cells to survive genotoxic events. In addition to this well characterized role in DNA repair, we now demonstrate a novel role for ATM in the retinoic acid (RA)-induced differentiation of SH-SY5Y neuroblastoma cells into post-mitotic, neuronal-like cells. RA rapidly activates the activity of ATM kinase, leading to the ATM-dependent phosphorylation of the CREB protein, extrusion of neuritic processes, and differentiation of SH-SY5Y cells into neuronal-like cells. When ATM protein expression was suppressed by short hairpin RNA, the ATM-dependent phosphorylation of CREB was blocked. Furthermore, ATM-negative cells failed to differentiate into neuronal-like cells when exposed to retinoic acid; instead, they underwent cell death. Expression of a constitutively active CREBVP16 construct, or exposure to forskolin to induce CREB phosphorylation, rescued ATM negative cells and restored differentiation. Furthermore, when dominant negative CREB proteins with mutations in either the CREB phosphorylation site (CREBS133A) or the DNA binding domain (KCREB) were introduced into SH-SY5Y cells, retinoic acid-induced differentiation was blocked and the cells underwent cell death. The results demonstrate that ATM is required for the retinoic acid-induced differentiation of SH-SY5Y cells through the ATM dependent-phosphorylation of serine 133 of CREB. These results therefore define a novel mechanism for activation of the activity of ATM kinase by RA, and implicate ATM in the regulation of CREB function during RA-induced differentiation.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Cycle Proteins/metabolism , Cell Differentiation/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , DNA-Binding Proteins/metabolism , Neuroblastoma/enzymology , Protein Serine-Threonine Kinases/metabolism , Tretinoin/pharmacology , Tumor Suppressor Proteins/metabolism , Amino Acid Substitution , Ataxia Telangiectasia Mutated Proteins , Cell Differentiation/genetics , Cell Line, Tumor , Cyclic AMP Response Element-Binding Protein/genetics , DNA Damage/genetics , DNA Repair/genetics , Genes, Dominant , Humans , Mutation, Missense , Neurites/enzymology , Neurites/pathology , Neuroblastoma/genetics , Neuroblastoma/pathology , Neurodegenerative Diseases/enzymology , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , Protein Processing, Post-Translational/genetics , Protein Structure, Tertiary/genetics , Signal Transduction/drug effects , Signal Transduction/genetics
3.
Proc Natl Acad Sci U S A ; 99(6): 3794-9, 2002 Mar 19.
Article in English | MEDLINE | ID: mdl-11904433

ABSTRACT

The Cbl-family ubiquitin ligases function as negative regulators of activated receptor tyrosine kinases by facilitating their ubiquitination and subsequent targeting to lysosomes. Cbl associates with the lymphoid-restricted nonreceptor tyrosine kinase Lck, but the functional relevance of this interaction remains unknown. Here, we demonstrate that T cell receptor and CD4 coligation on human T cells results in enhanced association between Cbl and Lck, together with Lck ubiquitination and degradation. A Cbl(-/-) T cell line showed a marked deficiency in Lck ubiquitination and increased levels of kinase-active Lck. Coexpression in 293T cells demonstrated that Lck kinase activity and Cbl ubiquitin ligase activity were essential for Lck ubiquitination and negative regulation of Lck-dependent serum response element-luciferase reporter activity. The Lck SH3 domain was pivotal for Cbl-Lck association and Cbl-mediated Lck degradation, with a smaller role for interactions mediated by the Cbl tyrosine kinase-binding domain. Finally, analysis of a ZAP-70-deficient T cell line revealed that Cbl inhibited Lck-dependent mitogen-activated protein kinase activation, and an intact Cbl RING finger domain was required for this functional effect. Our results demonstrate a direct, ubiquitination-dependent, negative regulatory role of Cbl for Lck in T cells, independent of Cbl-mediated regulation of ZAP-70.


Subject(s)
Ligases/metabolism , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Proto-Oncogene Proteins/metabolism , Ubiquitin/metabolism , CD4 Antigens/metabolism , Cell Line , Enzyme Activation , Gene Deletion , Genes, Reporter/genetics , Humans , Jurkat Cells , Ligases/chemistry , Ligases/deficiency , Ligases/genetics , Lymphocyte Activation , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/antagonists & inhibitors , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/chemistry , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/genetics , Protein Binding , Protein Processing, Post-Translational , Protein Structure, Tertiary , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/chemistry , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-cbl , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Ubiquitin-Protein Ligases , ZAP-70 Protein-Tyrosine Kinase , src Homology Domains
SELECTION OF CITATIONS
SEARCH DETAIL
...